Nasdaq · CIK 0001595248
GNPX Genprex, Inc.
Insider trading from SEC Form 4. Last filing Feb 19, 2025. Close $2.72 on Oct 9, 2026, +6% from the 52-week low and -100% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Genprex, Inc., scored.
Congressional trades
4 trades in GNPX disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Tim Moore House · R-NC | Purchase | GNPX Genprex, Inc. - Common Stock | $1,001 to $15k | Feb 5 / Feb 20 15 days after the trade | Clerk |
Tim Moore House · R-NC | Purchase | GNPX Genprex, Inc. - Common Stock | $1,001 to $15k | Dec 18, 2025 / Jan 7 20 days after the trade | Clerk |
Tim Moore House · R-NC | Purchase | GNPX Genprex, Inc. - Common Stock | $1,001 to $15k | Nov 7, 2025 / Dec 2, 2025 25 days after the trade | Clerk |
Tim Moore House · R-NC | Purchase | GNPX Genprex, Inc. - Common Stock | $15k to $50k | Oct 29, 2025 / Nov 12, 2025 14 days after the trade | Clerk |
Transactions
The last 7 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Mark Stanley Berger Chief Medical Officer | FTax withholding Common Stock | -585 | $0.41 | $240 | 22,471 | Feb 19, 2025 |
| Feb 18, 2025 | Ryan M. Confer President, CEO and CFO | FTax withholding Common Stock | -395 | $0.41 | $162 | 38,743 | Feb 19, 2025 |
| Dec 5, 2024 | Mark Stanley Berger Chief Medical Officer | AGrant or award Common Stock | +18,250 | $0.00 | $0 | 23,056 | Dec 6, 2024 |
| Dec 5, 2024 | Ryan M. Confer President, CEO and CFO | AGrant or award Common Stock | +29,375 | $0.00 | $0 | 39,138 | Dec 6, 2024 |
| Dec 5, 2024 | Brent M Longnecker director | AGrant or award Common Stock | +4,750 | $0.00 | $0 | 8,220 | Dec 6, 2024 |
| Dec 5, 2024 | William R Wilson Jr. director | AGrant or award Common Stock | +4,750 | $0.00 | $0 | 7,845 | Dec 6, 2024 |
| Dec 5, 2024 | Toscano Jose Antonio Moreno director | AGrant or award Common Stock | +4,750 | $0.00 | $0 | 7,845 | Dec 6, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Mark Stanley BergerChief Medical Officer
- Ryan M. ConferPresident, CEO and CFO
- Brent M Longneckerdirector
- Toscano Jose Antonio Morenodirector
- William R Wilson Jr.director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.